Cl-Amidine (trifluoroacetate salt): PAD4 Inhibition in Disease Models

Executive Summary: Cl-Amidine (trifluoroacetate salt) is a small-molecule inhibitor targeting protein arginine deiminase 4 (PAD4), with an IC₅₀ of 5.9 μM in vitro (source: product_spec). It selectively inhibits PAD4-mediated citrullination of histones, modulating gene expression linked to cancer and rheumatoid arthritis (source: DOI). In murine models of septic shock, Cl-Amidine restores innate immune cell populations and improves survival (source: product_spec). The compound is highly soluble in DMSO and water with ultrasonic assistance; insoluble in ethanol. APExBIO supplies Cl-Amidine (SKU: C3829) as a crystalline solid for research use.

Biological Rationale

Protein arginine deiminase 4 (PAD4) catalyzes the conversion of arginine residues on histones to citrulline, a post-translational modification that regulates chromatin structure and gene expression (source: DOI). Dysregulation of PAD4 activity is implicated in carcinogenesis, particularly in acute myeloid leukemia (AML), where aberrant transcription factor complexes and epigenetic alterations contribute to differentiation block and malignant transformation. PAD4-driven histone citrullination has also been linked to aberrant immune responses and autoimmunity, as seen in rheumatoid arthritis research. Selective chemical inhibition of PAD4, such as with Cl-Amidine, offers a targeted approach to dissect the role of histone deimination in disease pathogenesis and to modulate gene regulatory pathways in preclinical models. For a broader review of translational epigenetics and PAD4 inhibition, see Expanding the Frontiers of Translational Epigenetics, which this article extends with product-specific benchmarks and workflow guidance.

Mechanism of Action of Cl-Amidine (trifluoroacetate salt)

Cl-Amidine is a synthetic amidine derivative that irreversibly inhibits PAD4 by covalently modifying the active-site cysteine residue (source: mechanistic review). By blocking PAD4 catalytic activity, Cl-Amidine prevents the deimination of arginine residues on histone H3 and H4, thereby reducing histone citrullination and altering gene transcription. The trifluoroacetate salt form offers improved solubility, facilitating its use in in vitro and in vivo assays. The high selectivity of Cl-Amidine for PAD4 over other PAD isoforms enables targeted interrogation of PAD4-specific pathways in cancer and inflammatory models. For a detailed discussion of PAD4 deimination activity assays and selectivity, see Cl-Amidine (Trifluoroacetate Salt): PAD4 Deimination Activity Inhibitor, which this article updates by including recent in vivo efficacy data.

Evidence & Benchmarks

• Cl-Amidine (trifluoroacetate salt) exhibits an IC₅₀ of 5.9 μM against human PAD4 in vitro (source: product_spec).
• In murine cecal ligation and puncture (CLP) septic shock models, Cl-Amidine treatment restores innate immune cell populations and enhances survival (source: product_spec).
• Cl-Amidine reduces bone marrow and thymus atrophy, increases blood monocyte counts, enhances bacterial clearance, and attenuates pro-inflammatory cytokine production in vivo (source: product_spec).
• The compound is highly soluble in DMSO (≥20.55 mg/mL) and in water with ultrasound (≥9.53 mg/mL), but insoluble in ethanol (source: product_spec).
• No clinical trial data are available for Cl-Amidine as of June 2024 (source: product_spec).
• PAD4 inhibition is mechanistically linked to altered gene expression in cancer and autoimmune disease models (source: DOI).

For mechanistic insights connecting PAD4 inhibition to ribosome biogenesis and advanced applications in cancer research, see Cl-Amidine trifluoroacetate salt: PAD4 Inhibition at the Translational Frontier. This article provides updated in vivo benchmarks and addresses workflow compatibility, clarifying previous overviews.

Applications, Limits & Misconceptions

Applications: Cl-Amidine trifluoroacetate salt is widely used in cancer research to dissect the role of PAD4-driven histone citrullination and gene regulation, especially in acute myeloid leukemia (AML) and models of rheumatoid arthritis (source: DOI). It is also applied in inflammatory and septic shock murine models to study immune modulation. The compound's high solubility and selectivity support its use in PAD4 enzyme activity assays, epigenetic studies, and translational research workflows (source: product_spec).

Common Pitfalls or Misconceptions

• Cl-Amidine does not inhibit all PAD isoforms equally; it is highly selective for PAD4 (source: mechanistic review).
• The compound is insoluble in ethanol and will precipitate if ethanol is used as a solvent (source: product_spec).
• No human clinical trial data exists for Cl-Amidine, and safety/efficacy in humans remain unproven (source: product_spec).
• Long-term storage of solutions is not recommended; solutions should be freshly prepared for each experiment (source: product_spec).
• PAD4 inhibition should not be conflated with inhibition of general arginine methylation or acetylation processes.

Workflow Integration & Parameters

Protocol Parameters

• PAD4 enzyme activity assay | 5.9 μM IC₅₀ | in vitro PAD4 inhibition | Quantifies direct potency of Cl-Amidine | product_spec
• Solubility in DMSO | ≥20.55 mg/mL | stock preparation for in vitro/in vivo use | Ensures robust assay setup | product_spec
• Solubility in water (ultrasound) | ≥9.53 mg/mL | alternate solvent for aqueous systems | Facilitates compatibility in murine models | product_spec
• Storage temperature | –20°C | solid and solution forms | Preserves compound stability | product_spec
• Recommended solution use | immediate (short-term only) | all workflows | Prevents compound degradation | product_spec

For workflow-optimized studies, see Cl-Amidine (Trifluoroacetate Salt): PAD4 Deimination Activity Inhibitor, which this article extends by integrating recent in vivo protocols and storage guidelines.

Conclusion & Outlook

Cl-Amidine (trifluoroacetate salt) provides a selective, potent means to inhibit PAD4, enabling targeted dissection of histone citrullination pathways in cancer and inflammatory models. The compound’s robust in vitro potency, solubility, and validated in vivo effects in murine models position it as a preferred tool for epigenetic and immune research. While clinical data are lacking, preclinical evidence supports the continued integration of Cl-Amidine into translational pipelines for cancer and autoimmune research (source: DOI). Future studies will clarify its therapeutic potential and limitations in the context of complex disease mechanisms. For product specifications and ordering information, see APExBIO Cl-Amidine (trifluoroacetate salt) C3829.